Table E11.
Multivariate∗ analysis for the association between steroids use in the previous year (yes/no) and the composite of moderate to severe COVID-19 or all-cause mortality within 90 d following PCR date among adult asthmatic patients with positive PCR test result for SARS-CoV-2 (n = 8242)
| Variable | Adjusted∗ HR (95% CI) | P value |
|---|---|---|
| Age (for each year increase) | 1.057 (1.051-1.063) | <.001 |
| Sex | ||
| Males | 1.25 (1.04-1.50) | .015 |
| Females | Reference | |
| Ethnicity | ||
| Jews | Reference | |
| Arabs | 1.56 (1.30-1.87) | <.001 |
| Diabetes | 1.36 (1.13-1.63) | .001 |
| Hypertension | 1.36 (1.08-1.72) | .008 |
| Obesity | 1.36 (1.13-1.63) | .001 |
| IHD | 1.36 (1.12-1.65) | .002 |
| Smoking (ever) | 0.93 (0.77-1.11) | .418 |
| Steroids use in the previous year | ||
| None | Reference | |
| Yes | 1.38 (1.16-1.64) | <.001 |
| Biologics use (at least 1 prescription filled in the previous 120 d) | ||
| None | Reference | |
| Yes | 1.65 (0.82-3.33) | .164 |
IHD, Ischemic heart disease.
∗
Adjusted for age, sex, ethnicity, diabetes, hypertension, IHD, obesity, smoking, and steroids and biologics use.